Here's the lithium price forecast through to 2025

Will lithium prices still be booming in 2025?

| More on:
a miniature moulded model of a man bent over with a pick working stands behind a sign that has lithium's scientific abbreviation 'Li' with the word lithium underneath it against a sparse bland background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performing areas of the Australian share market in 2022 has been the lithium industry. Thanks to sky high lithium prices, a number of lithium shares have recorded exceptionally strong gains for investors.

For example, as you can see below, the Pilbara Minerals Ltd (ASX: PLS) share price has been a strong performer again in 2022 and is smashing the market.

But Pilbara Minerals isn't the best performer in the industry, not by a long shot. A number of other lithium shares have outperformed the lithium giant with significantly stronger gains over the same period.

One of those is the Core Lithium Ltd (ASX: CXO) share price, which has more than doubled in value in 2022 and is up 150% on a 12-month basis.

But will lithium prices remain strong for long enough to justify these impressive gains? Let's take a look at what Goldman Sachs is saying about the white metal.

Where are lithium prices going?

Unfortunately, the commodity team at Goldman Sachs is expecting lithium prices to start to soften from the second half of next year. This is due largely to its belief that supply will finally catch up with demand and put downward pressure on both prices and lithium stocks. It commented:

Battery expansion related restocking demand and higher EV sales kept the market tighter in 2H22 than previously expected. Our commodity team now expect lithium prices through 1H23 to reflect the near-term tightness and lagging spodumene contract price pass-through before declining over 2H23. While we see earnings support for the Australian stocks over 12-18 months on price lags, on a 12m view we expect lithium stock prices to fall as lithium prices decline from record peaks.

Ultimately, Goldman is forecasting global lithium demand to grow to ~1,300kt LCE by 2025, but expects lithium production to hit ~1,700kt LCE.

In light of the above, its analysts expect lithium to command the following (per tonne):

  • Lithium carbonate
    • 2022 US$59,331
    • 2023 US$53,300
    • 2024 US$11,000
    • 2025 US$11,000
  • Lithium hydroxide
    • 2022 US$67,240
    • 2023 US$58,015
    • 2024 US$12,500
    • 2025 US$12,500
  • Spodumene 6%
    • 2022 US$4,233
    • 2023 US$4,330
    • 2024 US$800
    • 2025 US$800

If Goldman Sachs is on the money with its estimates, then it could be bad news for developer/explorers that aren't expected to be producing lithium for a couple of years. By the time their operations come on line, they could be dealing with wildly different lithium prices.

Therefore, it might be time to rethink the valuations of lithium shares such as AVZ Minerals Ltd (ASX: AVZ) and Vulcan Energy Resources Ltd (ASX: VUL).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »